Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brendan Frett

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
RSC Medicinal Chemistry|February 23, 2024
Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small moleculesBaku Acharya, Debasmita Saha, Daniel Armstrong, et al.
Bioorganic & Medicinal Chemistry|May 14, 2024
Discovery of 9H-pyrimido[4,5-b]indole derivatives as dual RET/TRKA inhibitorsBaku Acharya, Debasmita Saha, Noemi Garcia Garcia, et al.
Tetrahedron|October 23, 2018
Selective, C-3 Friedel-Crafts acylation to generate functionally diverse, acetylated Imidazo[1,2-<i>a</i>]pyridine derivativesBrendan Frett, Nicholas McConnell, Anupreet Kharbanda, et al.
Journal of Medicinal Chemistry|September 7, 2018
Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical ApplicationWei Yan, Naga Rajiv Lakkaniga, Francesca Carlomagno, et al.
European Journal of Medicinal Chemistry|July 11, 2021
Discovery and biological evaluation of phthalazines as novel non-kinase TGFβ pathway inhibitorsAnupreet Kharbanda, Lingtian Zhang, Debasmita Saha, et al.
Journal of Medicinal Chemistry|August 26, 2020
Correction to Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical ApplicationWei Yan, Naga Rajiv Lakkaniga, Francesca Carlomagno, et al.
European Journal of Medicinal Chemistry|March 2, 2021
Discovery of pyrazolo-thieno[3,2-d]pyrimidinylamino-phenyl acetamides as type-II pan-tropomyosin receptor kinase (TRK) inhibitors: Design, synthesis, and biological evaluationWei Yan, Lingtian Zhang, Fengping Lv, et al.
Scientific Reports|March 1, 2018
Rational Design, Synthesis and Biological Evaluation of Pyrimidine-4,6-diamine derivatives as Type-II inhibitors of FLT3 Selective Against c-KITJaideep B Bharate, Nicholas McConnell, Gunaganti Naresh, et al.
Angewandte Chemie (International Ed. in English)|July 2, 2015
Fragment-Based Discovery of a Dual pan-RET/VEGFR2 Kinase Inhibitor Optimized for Single-Agent PolypharmacologyBrendan Frett, Francesca Carlomagno, Maria Luisa Moccia, et al.
European Journal of Medicinal Chemistry|September 3, 2021
Discovery of imidazo[1,2-a]pyridine-thiophene derivatives as FLT3 and FLT3 mutants inhibitors for acute myeloid leukemia through structure-based optimization of an NEK2 inhibitorLingtian Zhang, Naga Rajiv Lakkaniga, Jaideep B Bharate, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
RSC Medicinal Chemistry|February 23, 2024
Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small moleculesBaku Acharya, Debasmita Saha, Daniel Armstrong, et al.
Bioorganic & Medicinal Chemistry|May 14, 2024
Discovery of 9H-pyrimido[4,5-b]indole derivatives as dual RET/TRKA inhibitorsBaku Acharya, Debasmita Saha, Noemi Garcia Garcia, et al.
Tetrahedron|October 23, 2018
Selective, C-3 Friedel-Crafts acylation to generate functionally diverse, acetylated Imidazo[1,2-<i>a</i>]pyridine derivativesBrendan Frett, Nicholas McConnell, Anupreet Kharbanda, et al.
Journal of Medicinal Chemistry|September 7, 2018
Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical ApplicationWei Yan, Naga Rajiv Lakkaniga, Francesca Carlomagno, et al.
European Journal of Medicinal Chemistry|July 11, 2021
Discovery and biological evaluation of phthalazines as novel non-kinase TGFβ pathway inhibitorsAnupreet Kharbanda, Lingtian Zhang, Debasmita Saha, et al.
Journal of Medicinal Chemistry|August 26, 2020
Correction to Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical ApplicationWei Yan, Naga Rajiv Lakkaniga, Francesca Carlomagno, et al.
European Journal of Medicinal Chemistry|March 2, 2021
Discovery of pyrazolo-thieno[3,2-d]pyrimidinylamino-phenyl acetamides as type-II pan-tropomyosin receptor kinase (TRK) inhibitors: Design, synthesis, and biological evaluationWei Yan, Lingtian Zhang, Fengping Lv, et al.
Scientific Reports|March 1, 2018
Rational Design, Synthesis and Biological Evaluation of Pyrimidine-4,6-diamine derivatives as Type-II inhibitors of FLT3 Selective Against c-KITJaideep B Bharate, Nicholas McConnell, Gunaganti Naresh, et al.
Angewandte Chemie (International Ed. in English)|July 2, 2015
Fragment-Based Discovery of a Dual pan-RET/VEGFR2 Kinase Inhibitor Optimized for Single-Agent PolypharmacologyBrendan Frett, Francesca Carlomagno, Maria Luisa Moccia, et al.
European Journal of Medicinal Chemistry|September 3, 2021
Discovery of imidazo[1,2-a]pyridine-thiophene derivatives as FLT3 and FLT3 mutants inhibitors for acute myeloid leukemia through structure-based optimization of an NEK2 inhibitorLingtian Zhang, Naga Rajiv Lakkaniga, Jaideep B Bharate, et al.
Pageof 6